Else Nutrition Holdings Inc. reports developments tied to its plant-based nutrition business for infants, toddlers, children, and adults. The company’s updates center on whole-food, non-soy, non-dairy products, including toddler nutrition and baby cereal lines made with ingredients such as almonds, buckwheat, and tapioca.
Recurring news themes include U.S. infant-formula regulatory activity, FDA guidance on protein standards, product pipeline positioning, sales milestones, operating and financial progress, shareholder meeting results, governance matters, and capital-structure actions related to convertible funding agreements and equity issuance approvals.
Else Nutrition Holdings Inc. (BABYF) has launched its Else Super Cereal, a first-of-its-kind baby cereal in the U.S. to receive the Clean Label Project Purity Award Certification, ensuring it meets rigorous safety standards. The plant-based cereal is available on Amazon starting this week at $6.99 per 7oz pouch. The product is designed for infants aged six months and older and includes four flavors, boasting balanced nutrition with essential vitamins and minerals while being free from allergens and artificial ingredients. Retail demand is reported to be strong.
Else Nutrition Holdings Inc. announced the successful expansion of its product line with the launch of Else Plant-Based Kids Shakes in chocolate and vanilla flavors, now available at all 65 Rouses Markets in Louisiana, Mississippi, and Alabama. These shakes, free from dairy, soy, and gluten, contain 50% less sugar than competitors and are based on clean, whole food ingredients. The company continues to receive accolades for its Toddler Nutrition line, which has garnered multiple awards, including the Good Housekeeping Parenting Award.
Else Nutrition Holdings Inc. has announced a significant expansion of its plant-based kids' shakes, following the successful launch of Else Toddler Nutrition at Big Y. The shakes, available in chocolate and vanilla, will be introduced in over 70 new locations across New England in Q2 2022. These shakes are made from clean ingredients like organic almonds and buckwheat, containing 50% less sugar than competitors, and aimed at supporting children's growth. Else Toddler Nutrition has received multiple awards, further solidifying the brand's position in the market.
Else Nutrition Holdings Inc (BABYF) reported impressive financials for FY 2021, with revenues soaring 219% to $4.7M compared to $1.5M in FY 2020, fueled by successful product expansions. Q4 2021 revenue reached $1.3M, an 8% increase from Q3 2021. The company holds a robust cash balance of $25.5M and has graduated to the Toronto Stock Exchange. Projected revenues for Q1 2022 are estimated between $1.45M and $1.6M, indicating a sequential growth of 15% to 25%.
Else Nutrition Holdings Inc. has announced the upcoming launch of its new product, Else™ Toddler Omega, designed for toddlers aged 12-36 months. Scheduled for release on Amazon and its e-store, this nutrition drink features added Omega 3 and 6 fatty acids for enhanced brain and eye development. Priced at $29 for a 22oz can, the product aims to meet increased demand from customers and pediatricians. The company highlights its Clean Label Purity Award Certification for quality assurance, building on the success of its original nutrition product.
Summary not available.
Else Nutrition Holdings Inc. announced that its pre-clinical study of Plant-Based infant formula will be orally presented at the 9th International Conference on Nutrition and Growth, scheduled for March 17-19, 2022. This acceptance signifies valuable exposure for the company among leading experts in pediatric nutrition and development. The conference aims to foster interdisciplinary collaborations among pediatricians, nutritionists, and neonatologists. CEO Hamutal Yitzhak highlighted the importance of this development for showcasing Else's scientific advances.
Else Nutrition Holdings Inc. has successfully completed a preclinical study for its Plant-Based infant formula, a key step towards entering the $5 billion U.S. infant formula market and the $80 billion global market. The study showed growth comparable to dairy-based formulas, indicating nutrient bioavailability and safety needed for FDA approval. CEO Hamutal Yitzhak emphasized this as a significant milestone in their mission to provide a clean, plant-based formula. Full results will be presented at a pediatric nutrition conference in March 2022.
Else Nutrition Holdings Inc. has appointed Dr. Susan Baker, a tenured Pediatrics professor at the University of Buffalo, to its Scientific Advisory Board. Dr. Baker, with extensive experience in children's health and nutrition, has held notable positions including Chairperson of the American Academy of Pediatrics' Committee on Nutrition. Her insights are expected to significantly benefit Else Nutrition and its customer base. The Company focuses on innovative, plant-based nutrition products for infants and toddlers, and has recently received prestigious industry awards.
Else Nutrition Holdings Inc. has appointed Dr. Carlos Lifschitz to its Scientific Advisory Board, enhancing its expertise in pediatric nutrition. Dr. Lifschitz is an accomplished pediatric gastroenterologist with extensive experience and publications. CEO Hamutal Yitzhak expressed confidence that his knowledge will significantly contribute to the company's goal of providing clean, plant-based nutrition options for families. Else Nutrition focuses on innovative nutrition products, including award-winning plant-based formulas, and holds public listings under the symbols BABY, BABYF, and 0YL.